BRCA Genes: The Role in Genome Stability, Cancer Sternness and Therapy Resistance

被引:141
作者
Gorodetska, Ielizaveta [1 ,2 ,3 ]
Kozeretska, Iryna [4 ]
Dubrovska, Anna [1 ,2 ,5 ,6 ,7 ]
机构
[1] Tech Univ Dresden, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany
[2] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
[3] Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany
[4] Taras Shevchenko Natl Univ Kyiv, ESC Inst Biol & Med, Dept Gen & Med Genet, Kiev, Ukraine
[5] Helmholtz Zentrum Dresden Rossendorf, Inst Radiooncol OncoRay, Dresden, Germany
[6] German Canc Consortium DKTK, Partner Site Dresden, Dresden, Germany
[7] German Canc Res Ctr, Heidelberg, Germany
来源
JOURNAL OF CANCER | 2019年 / 10卷 / 09期
关键词
BRCA1; BRCA2; genomic instability; cancer stem cells; cancer treatment; DNA-DAMAGE RESPONSE; ESTROGEN-RECEPTOR-ALPHA; NEGATIVE BREAST-CANCER; ACUTE MYELOID-LEUKEMIA; GERM-LINE MUTATIONS; CELL-CYCLE ARREST; OVARIAN-CANCER; STEM-CELLS; HOMOLOGOUS RECOMBINATION; TUMOR-SUPPRESSOR;
D O I
10.7150/jca.30410
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Carcinogenesis is a multistep process, and tumors frequently harbor multiple mutations regulating genome integrity, cell division and death. The integrity of cellular genome is closely controlled by the mechanisms of DNA damage signaling and DNA repair. The association of breast cancer susceptibility genes BRCA1 and BRCA2 with breast and ovarian cancer development was first demonstrated over 20 years ago. Since then the germline mutations within these genes were linked to genomic instability and increased risk of many other cancer types. Genomic instability is an engine of the oncogenic transformation of non-tumorigenic cells into tumor-initiating cells and further tumor evolution. In this review we discuss the biological functions of BRCA1 and BRCA2 genes and the role of BRCA mutations in tumor initiation, regulation of cancer stemness, therapy resistance and tumor progression.
引用
收藏
页码:2109 / 2127
页数:19
相关论文
共 50 条
  • [31] The role of microRNA in resistance to breast cancer therapy
    Robertson, Neil M.
    Yigit, Mehmet V.
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2014, 5 (06) : 823 - 833
  • [32] The Role of Exosomal microRNA in Cancer Drug Resistance
    Guo, Qiao-ru
    Wang, Hui
    Yan, Ying-da
    Liu, Yun
    Su, Chao-yue
    Chen, Hu-biao
    Yan, Yan-yan
    Adhikari, Rameshwar
    Wu, Qiang
    Zhang, Jian-ye
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [33] The role of deubiquitinating enzymes in cancer drug resistance
    Tanguturi, Parthasaradhireddy
    Kim, Kye-Seong
    Ramakrishna, Suresh
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (04) : 627 - 639
  • [34] The role of PARP inhibitors in BRCA mutated pancreatic cancer
    Chi, Jeffrey
    Chung, Su Yun
    Parakrama, Ruwan
    Fayyaz, Fatima
    Jose, Jyothi
    Saif, Muhammad Wasif
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [35] Women's cancers: how the discovery of BRCA genes is driving current concepts of cancer biology and therapeutics
    Murthy, Pooja
    Muggia, Franco
    ECANCERMEDICALSCIENCE, 2019, 13
  • [36] Fanconi Anaemia, Childhood Cancer and the BRCA Genes
    Woodward, Emma R.
    Meyer, Stefan
    GENES, 2021, 12 (10)
  • [37] THE ROLE OF BRCA1, BRCA2 AND RAD51 PROTEINS IN THE MAINTENANCE OF GENOMIC STABILITY
    Nowacka-Zawisza, Maria
    Krajewska, Wanda Malgorzata
    POSTEPY BIOLOGII KOMORKI, 2009, 36 (04) : 679 - 694
  • [38] Alterations of cell cycle genes in cancer: unmasking the role of cancer stem cells
    Caglar, Hasan Onur
    Biray Avci, Cigir
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (04) : 3065 - 3076
  • [39] BBI608 inhibits cancer sternness and reverses cisplatin resistance in NSCLC
    MacDonagh, Lauren
    Gray, Steven G.
    Breen, Eamon
    Cuffe, Sinead
    Finn, Stephen P.
    O'Byrne, Kenneth J.
    Barr, Martin P.
    CANCER LETTERS, 2018, 428 : 117 - 126
  • [40] Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy
    Lorusso, Domenica
    Tripodi, Elisa
    Maltese, Giuseppa
    Lepori, Stefano
    Sabatucci, Ilaria
    Bogani, Giorgio
    Raspagliesi, Francesco
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1501 - 1509